Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
22.84
-0.07 (-0.31%)
At close: Dec 5, 2025, 4:00 PM EST
22.87
+0.03 (0.13%)
After-hours: Dec 5, 2025, 5:28 PM EST
Immunovant Market Cap
Immunovant has a market cap or net worth of $4.00 billion as of December 5, 2025. Its market cap has increased by 6.91% in one year.
Market Cap
4.00B
Enterprise Value
3.48B
1-Year Change
6.91%
Ranking
Category
Stock Price
$22.84
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $4.00B, an increase of 3,118.75%. That is a compound annual growth rate of 71.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |